XML 68 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative instruments and hedging activities - Summary Of Pre-tax (gains) losses from Derivatives Designated in Cash Flow Hedging Relationships (Detail) - Designated as Hedging Instrument [Member] - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Disclosure In Tabular Form Of Pretax Gain Loss Cash Flow Hedging Instruments [Line Items]    
Other comprehensive income (loss) $ 127 $ (57)
Cross Currency Swap Cash Flow Hedge [Member]    
Disclosure In Tabular Form Of Pretax Gain Loss Cash Flow Hedging Instruments [Line Items]    
Other comprehensive income (loss) [1] (2) 0
Financial Expenses Net [Member]    
Disclosure In Tabular Form Of Pretax Gain Loss Cash Flow Hedging Instruments [Line Items]    
Financial expenses, net 260 258
Financial Expenses Net [Member] | Cross Currency Swap Cash Flow Hedge [Member]    
Disclosure In Tabular Form Of Pretax Gain Loss Cash Flow Hedging Instruments [Line Items]    
Financial expenses, net [1] $ 1 $ 0
[1] On March 31, 2023, Teva entered into a cross currency interest rate swap agreement, designated as cash flow hedge for accounting purposes with respect to an intercompany loan due October 2026, denominated in Japanese yen.